ERIBULINE ADVANZ PHARMA 0,44 mg/mL, solution injectable — 1 flacon en verre de 2 mL

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930279304
  • CIP7 3027930
  • CIS 60267292

What the source publishes

Holder
ADVANZ PHARMA LIMITED
Active ingredients
ÉRIBULINE, MÉSILATE D'ÉRIBULINE
Form
solution injectable
Package
1 flacon en verre de 2 mL
Routes
intraveineuse
Administrative status
authorised
Supply regime
médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE
Marketing status
Déclaration de commercialisation
Authorised on
2023-09-14
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930279304
{
  "cis": "60267292",
  "cip7": "3027930",
  "form": "solution injectable",
  "name": "ERIBULINE ADVANZ PHARMA 0,44 mg/mL, solution injectable — 1 flacon en verre de 2 mL",
  "cip13": "3400930279304",
  "holder": "ADVANZ PHARMA LIMITED",
  "routes": [
    "intraveineuse"
  ],
  "holders": [
    "ADVANZ PHARMA LIMITED"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": null,
  "authorisedOn": "2023-09-14",
  "compositions": [
    {
      "name": "ÉRIBULINE",
      "nature": "FT",
      "strength": "0,44 mg",
      "linkageNumber": "1",
      "substanceCode": "21374",
      "dosageReference": "1 mL de solution",
      "pharmaceuticalElement": "solution"
    },
    {
      "name": "MÉSILATE D'ÉRIBULINE",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "67656",
      "dosageReference": null,
      "pharmaceuticalElement": "solution"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE",
  "dispensingFee": null,
  "medicinePrice": null,
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "ERIBULINE ADVANZ PHARMA 0,44 mg/mL, solution injectable",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-20",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "1 flacon en verre de 2 mL",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [],
  "marketingDeclaredOn": "2025-02-19",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "ÉRIBULINE",
    "MÉSILATE D'ÉRIBULINE"
  ],
  "authorisationProcedure": "Procédure décentralisée",
  "prescriptionConditions": [
    "médicament nécessitant une surveillance particulière pendant le traitement",
    "prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE",
    "prescription réservée aux spécialistes et services HEMATOLOGIE",
    "prescription hospitalière",
    "liste I",
    "prescription réservée aux médecins compétents en CANCEROLOGIE"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930279304"